Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study have?
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study has 305 citations in the OpenAlex counts ScholarIQ stores.
When was Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study published?
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study has 2003 year in the ScholarIQ index.
What is the open-access status of Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study?
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study has closed oa status in the ScholarIQ index.
What is the DOI of Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study?
The DOI for Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study is on the source record.
What is the PMID of Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study?
The PMID for Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study is on the source record.
What is the OpenAlex record for Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study?
The OpenAlex for Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study is on the source record.